Founding Chief Executive Officer and Director Olav Bergheim to Depart Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the “Company” or “Adagio”), a leading innovator in catheter ablation...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the “Company” or “Adagio”), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced, today...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the “Company”), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced that its CEO &...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM; “Adagio Medical”, “Adagio” or the “Company”), a leading innovator in catheter ablation technologies, today announced the completion of the first...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the “Company”), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced its sponsorship and...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the “Company”), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today provided a business update. Recent...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.07 | -8.04597701149 | 0.87 | 0.91 | 0.75 | 190892 | 0.80158224 | CS |
4 | -0.33 | -29.203539823 | 1.13 | 1.3577 | 0.75 | 1135419 | 1.11105848 | CS |
12 | -1.93 | -70.695970696 | 2.73 | 4.1999 | 0.75 | 511242 | 1.44527435 | CS |
26 | -7.4 | -90.243902439 | 8.2 | 9.08 | 0.75 | 256074 | 1.70756538 | CS |
52 | -7.4 | -90.243902439 | 8.2 | 9.08 | 0.75 | 256074 | 1.70756538 | CS |
156 | -7.4 | -90.243902439 | 8.2 | 9.08 | 0.75 | 256074 | 1.70756538 | CS |
260 | -7.4 | -90.243902439 | 8.2 | 9.08 | 0.75 | 256074 | 1.70756538 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約